688131 Stock Overview
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Shanghai Haoyuan Chemexpress Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥37.95 |
| 52 Week High | CN¥48.39 |
| 52 Week Low | CN¥17.86 |
| Beta | 0.58 |
| 11 Month Change | -1.09% |
| 3 Month Change | 97.86% |
| 1 Year Change | -14.99% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688131 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -2.2% | -3.9% | -2.8% |
| 1Y | -15.0% | -33.2% | 2.0% |
Return vs Industry: 688131 exceeded the CN Life Sciences industry which returned -31.4% over the past year.
Return vs Market: 688131 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 688131 volatility | |
|---|---|
| 688131 Average Weekly Movement | 14.0% |
| Life Sciences Industry Average Movement | 10.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688131's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688131's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 3,437 | Baofu Zheng | www.chemexpress.cn |
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Shanghai Haoyuan Chemexpress Co., Ltd. Fundamentals Summary
| 688131 fundamental statistics | |
|---|---|
| Market cap | CN¥8.00b |
| Earnings (TTM) | CN¥152.63m |
| Revenue (TTM) | CN¥2.12b |
52.4x
P/E Ratio3.8x
P/S RatioIs 688131 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688131 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.12b |
| Cost of Revenue | CN¥1.25b |
| Gross Profit | CN¥871.92m |
| Other Expenses | CN¥719.29m |
| Earnings | CN¥152.63m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.72 |
| Gross Margin | 41.07% |
| Net Profit Margin | 7.19% |
| Debt/Equity Ratio | 36.3% |
How did 688131 perform over the long term?
See historical performance and comparison